@article{b81d73c0b8a84d1bb4aa3536c8f2d430,
title = "Immune responses to Neisseria gonorrhoeae and implications for vaccine development",
keywords = "gonococcus, gonorrhea, immunology, Neisseria, STI, vaccines",
author = "Thomas Belcher and Rollier, {Christine S.} and Christina Dold and Ross, {Jonathan D.C.} and MacLennan, {Calman A.}",
note = "Funding Information: Research reported in this publication is supported by CARB-X. CARB-X{\textquoteright}s funding for this project is provided in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority; under agreement number: 75A50122C00028, and by awards from Wellcome (WT224842), Germany{\textquoteright}s Federal Ministry of Education and Research (BMBF), and the UK Global Antimicrobial Resistance Innovation Fund (GAMRIF) funded by the UK Government Department of Health and Social Care (DHSC). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of CARB-X or any of its funders. Acknowledgments Publisher Copyright: Copyright {\textcopyright} 2023 Belcher, Rollier, Dold, Ross and MacLennan.",
year = "2023",
doi = "10.3389/fimmu.2023.1248613",
language = "English",
volume = "14",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media",
}